| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biolife Solutions, Inc.'s insiders have reduced their positions by a net 1,200,000 shares worth roughly $28.1M.
Classified under Health Care Equipment & Supplies (Health Care sector), BLFS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.76M | $164.88M | - | |
| CEO | 733.7K | $25.43M | - | |
| VP | 388.5K | $13.46M | - | |
| CFO | 213.2K | $7.39M | - | |
| Other | 162.6K | $5.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Foster Karen A.67 | Chief Quality And Operations | Sell | 328 | $27.02 | $8,862.56 | -0.2% | -19.5% | -3.3% | |
| Jan 6, 2025 | Wichterman Troy60 | Chief Financial Officer | Sell | 987 | $27.02 | $26,668.74 | -0.8% | -19.5% | -3.3% | |
| Dec 17, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 20,800 | $27.22 | $566,220.68 | -3.7% | -3.5% | -6.9% | |
| Nov 26, 2024 | Wichterman Troy60 | Chief Financial Officer | Sell | 581 | $27.20 | $15,803.20 | -0.5% | -5.0% | -1.4% | |
| Nov 26, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 523 | $27.20 | $14,225.60 | -0.2% | -5.0% | -1.4% | |
| Nov 26, 2024 | Berard Todd67 | Chief Marketing Officer | Sell | 349 | $27.20 | $9,492.80 | -0.3% | -5.0% | -1.4% | |
| Nov 26, 2024 | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 216 | $27.20 | $5,875.20 | -0.4% | -5.0% | -1.4% | |
| Nov 26, 2024 | Foster Karen A.67 | Chief Quality And Operations | Sell | 252 | $27.20 | $6,854.40 | -0.2% | -5.0% | -1.4% | |
| Nov 18, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sale+OE | 42,604 | $20.70 | $882,110.20 | -4.5% | +38.3% | +17.4% | |
| Nov 12, 2024 | Berard Todd67 | Chief Marketing Officer | Sell | 91 | $26.34 | $2,396.94 | - | -2.2% | -2.2% |